Observational studyCurrent oncology (Toronto, Ont.)2024

The Clinical Utilisation and Duration of Treatment with HER2-Directed Therapies in HER2-Positive Recurrent or Metastatic Salivary Gland Cancers.

Joseph Edward Haigh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.